Comparison of antifungal activity of fluconazole and clove leaf essential oil on Candida species isolate in HIV/AIDS patients with oral candidiasis
Keywords:
oral candidiasis, fluconazole, clove leaf, antifungal, HIV/AIDSAbstract
Current treatment guidelines include fluconazole as the main therapeutic option for treating oral candidiasis infection in HIV/AIDS patients, but resistance increases. Several in vitro studies have shown that clove leaf essential oil with the main content of eugenol can be an alternative therapy for oral candidiasis that is resistant to fluconazole. This study was conducted to determine the zone of inhibition of clove leaf essential oil and fluconazole against Candida isolates species that cause oral candidiasis in HIV/AIDS patients. This study showed that the average fluconazole disk 25 μg/mL inhibition zone in 20 isolates of Candida albicans species was larger than non-albicans Candida species. The zone of inhibition of clove leaf essential oil was significantly lower than that of fluconazole (p < 0.05), except at a concentration of 15% against non-albicans Candida isolates. Clove leaf essential oil has an antifungal effect that can inhibit the growth of Candida species, so it can be considered an alternative antifungal therapy. Clove leaf essential oil concentration of 15% showed no significant difference in antifungal activity with the standard drug fluconazole in isolates of non-albicans Candida species.
Downloads
References
Alshaik, N., & Kahkashan, P. (2017). Anti-candidal Activity and Chemical Composition of Essential Oil of Clove (Syzygium aromaticum). Journal of Essential Oil Bearing Plants, 20(4), 951–958. https://doi.org/10.1080/0972060X.2017.1375867
Andayani, A., Susilowati, A., & Pangastuti, A. (2014). Anti Candida minyak atsiri lengkuas putih (Alpinia galanga) terhadap Candida albicans penyebab candidiasis secara invitro. El Vivo, 2(2), 2014.
Berkow, E. L., & Lockhart, S. R. (2017). Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist, 10(1), 237–245. https://doi.org/10.2147/IDR.S118892
Bhuiyan, N. I., Begum, J., Nandi, N. C., & Akter, F. (2010). Constituents of the essential oil from leaves and buds of clove (Syzigium caryophyllatum (L.) Alston). African Journal of Plant Science, 4(11), 451–454.
Dar, M. S., Sreedar, G., Shukla, A., Gupta, P., Rehan, A. D., & George, J. (2015). An in vitro study of antifungal drug susceptibility of Candida species isolated from human immunodeficiency virus seropositive and human immunodeficiency virus seronegative individuals in Lucknow population Uttar Pradesh. J Oral Maxillofac Pathol, 19(2), 205–211. https://doi.org/10.4103/0973-029X.164534
Fristiyanti, R. A. (2019). Uji Efektivitas Antijamur Ekstrak Etanol Daun Cengkeh (Syzygium Aromaticum) Terhadap Pertumbuhan Candida Albicans Secara In Vitro. Universitas Brawijaya.
Gupta, C., & Prakash, D. (2021). Comparative Study of the Antimicrobial Activity of Clove Oil and Clove Extract on Oral Pathogens. Dentistry – Open Journal, 7(1), 12–15. https://doi.org/10.17140/doj-7-144
Houshmandzad, M., Sharifzadeh, A., Khosravi, A., & Shokri, H. (2022). Potential antifungal impact of citral and linalool administered individually or combined with fluconazole against clinical isolates of Candida krusei. Journal of Herbmed Pharmacology, 11(2), 269–277. https://doi.org/10.34172/jhp.2022.32
Jawetz, M., & Adelberg. (2007). Mikrobiologi Kedokteran (23rd ed.). Jakarta: ISBN 978-979- 448-859-1.
Khalil, A. A., Rahman, U. U., Khan, M. R., Sahar, A., Mehmood, T., & Khan, M. (2017). Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives. RSC Advances, 7(52), 32669–32681. https://doi.org/10.1039/c7ra04803c
Khan, M. S. A., & Ahmad, I. (2012). Antibiofilm activity of certain phytocompounds and their synergy with fluconazole against Candida albicans biofilms. J Antimicrob Chemother, 67(3), 618–621. https://doi.org/10.1093/jac/dkr512
Khansa, R. M. (2019). Uji aktivitas minyak atsiri bunga cengkeh (syzygium aromaticum l.) Dalam menghambat pertumbuhan jamur Candida albicans secara in vitro. Politeknik Kesehatan Kementerian Kesehatan, Yogyakarta.
Mulu, A., Kassu, A., Anagaw, B., Moges, B., Gelaw, A., Alemayehu, M., … Isogai, E. (2013). Frequent detection of “azole” resistant Candida species among late presenting AIDS patients in northwest Ethiopia. BMC Infectious Diseases, 13(1), 1. https://doi.org/10.1186/1471-2334-13-82
Murtiastutik, D, & Maharani, C. S. (2019). Profile of Candida Resistancy to Fluconazole in Male Patient with Oral Candidiasis and HIV/AIDS. Journal of AIDS & Clinical …, 10(1), 1–6.
Murtiastutik, Dwi, Prakoswa, C. R. S., Tantular, I. S., Ervianti, E., Hidayati, A. N., & Listiawan, M. Y. (2021). Correlation between CD4 T lymphocyte and candida species counts in oral candidiasis patients with HIV / AIDS. Indian Journal of Forensic Medicine and Toxicology, 15(1), 1013–1020. https://doi.org/10.37506/ijfmt.v15i1.13548
Musta, R., & Nurliana, L. (2019). Studi Kinetika Efektifitas Minyak Daun Cengkeh (Syzigium aromaticum) Sebagai Antifungi Candida albicans. Indo. J. Chem. Res., 6(2), 107–114. https://doi.org/10.30598//ijcr.2019.6-rus
Nurdjannah, N., & N., B. (2012). Cloves (2nd ed.). Indonesian Agency for Agriculture Research and Development (IAARD).
Pinto, E., Vale-Silva, L., Cavaleiro, C., & Salgueiro, L. (2009). Antifungal activity of the clove essential oil from Syzygium aromaticum on Candida, Aspergillus and dermatophyte species. Journal of Medical Microbiology, 58(11), 1454–1462. https://doi.org/10.1099/jmm.0.010538-0
Pudjiati, S. R., Ramali, L. M., Hidayati, A. N., Daili, S. F., & Niode, N. J. (2018). Kandidiasis mukokutan pada pasien HIV dan AIDS. In Manifestasi dan Tatalaksana Kelainan Kulit dan Kelamin pada Pasien HIV/AIDS (pp. 135–151). Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia.
Rosana, Y., Yasmon, A., & Lestari, D. C. (2015). Overexpression and mutation as a genetic mechanism of fluconazole resistance in candida albicans isolated from human immunodeficiency virus patients in Indonesia. Journal of Medical Microbiology, 64(9), 1046–1052. https://doi.org/10.1099/jmm.0.000123
Sadeghi, G., Ebrahimi-Rad, M., Mousavi, S. F., Shams-Ghahfarokhi, M., & Razzaghi-Abyaneh, M. (2018). Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile. Journal de Mycologie Medicale, 28(1), 51–58. https://doi.org/10.1016/j.mycmed.2017.12.008
Sakkas, H., Gousia, P., Petsios, S., Economou, V., & Papadopoulou, C. (2016). Antifungal activity of four essential oils against Candida clinical isolates Antibiotic resistance View project Antifungal activity of four essential oils against Candida clinical isolates. Asian Journal of Ethnopharmacology and Medicinal Foods, (01), 22.
Schmidt, E., Jirovetz, L., Wlcek, K., Buchbauer, G., Gochev, V., Girova, T., … Geissler, M. (2007). Antifungal Activity of Eugenol and Various Eugenol-Containing Essential Oils against 38 Clinical Isolates of Candida albicans. Journal of Essential Oil-Bearing Plants, 10(5), 421–429. https://doi.org/10.1080/0972060X.2007.10643575
Sumalapao, D. E. P., Rippey, C., Atienza, H. B. P., Cabrera, E. C., Flores, M. J. C., Amalin, D. M., … Gloriani, N. G. (2018). Susceptibility kinetic profile of Candida albicans biofilm on latex silicone surfaces with antifungal azoles. Current Research in Environmental and Applied Mycology, 8(6), 564–571. https://doi.org/10.5943/cream/8/6/1
Tappuni, A. R. (2020). The global changing pattern of the oral manifestations of HIV. Oral Diseases, 26(S1), 22–27. https://doi.org/10.1111/odi.13469
Williams, D. W., Kuriyama, T., Silva, S., Malic, S., & Lewis, M. A. O. (2011). Candida biofilms and oral candidosis: Treatment and prevention. Periodontology 2000, 55(1), 250–265. https://doi.org/10.1111/j.1600-0757.2009.00338.x
Suryasa, W., Sudipa, I. N., Puspani, I. A. M., & Netra, I. (2019). Towards a Change of Emotion in Translation of Kṛṣṇa Text. Journal of Advanced Research in Dynamical and Control Systems, 11(2), 1221-1231.
Sarada, V., & Mallikarjuna, T. (2018). Socio-economic and psychological problems of third gender people living with HIV/AIDS: A study in A.P. International Journal of Health & Medical Sciences, 1(1), 10-17. https://doi.org/10.31295/ijhms.v1n1.34
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.